Academic Journal
Q2Frontiers in Oncology
About Frontiers in Oncology
Frontiers in Oncology is a scholarly journal published by Frontiers Media SA. SCImago 2025 places it in Q2 with an SJR of 1.02 and an H-index of 173.
Its listed coverage is 2011-2026 and its research categories include Cancer Research (Q2); Oncology (Q2). The 2025 dataset reports 4138 documents and 58630 citations across the latest three-year reporting window.
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
The journal publishes research related to Cancer Immunotherapy and Biomarkers, Ferroptosis and cancer prognosis, Radiomics and Machine Learning in Medical Imaging, Cancer-related molecular mechanisms research, Glioma Diagnosis and Treatment, Lung Cancer Treatments and Mutations.
Recent Research Articles
Latest publications matched automatically by ISSN.
Component-based CT radiomics for preoperative differentiation of well-differentiated and dedifferentiated retroperitoneal liposarcoma
Ke Liu, Junxiang Zhang, Yaru Ren, Haochen Wang et al.
2026-09-09 · DOI: 10.3389/fonc.2026.1924254Trends and future burden of major digestive system cancers in Jiangsu Province, China, 2010–2030
Yanzheng Zou, Wei Wang, Luqiu Tao, Hongru Zhu et al.
2026-09-09 · DOI: 10.3389/fonc.2026.1902194Evaluating the impacts of previous breast surgery on surgical complications and aesthetic outcomes in reverse-sequence endoscopic-assisted nipple-sparing mastectomy with or without direct-to-implant breast reconstruction
Xiaoman Cao, Tao Zhu, Tianyuan Li, Zhongjian Zhu et al.
2026-09-09 · DOI: 10.3389/fonc.2026.1860773Molecularly informed preoperative and response-adapted management of colorectal cancer: evidence, decision boundaries, and emerging directions
Wenjing Hao, Yan Liu, Haidong Cheng, Mingxing Hou et al.
2026-09-09 · DOI: 10.3389/fonc.2026.1894870ASL perfusion radiomic heterogeneity is associated with early mortality in IDH-wildtype glioblastoma, beyond tumor volume: a time-varying effect with tumor-aware DTI-ALPS
Rafail C. Christodoulou, Georgios Vamvouras, Platon S. Papageorgiou, Evros Vassiliou et al.
2026-09-09 · DOI: 10.3389/fonc.2026.1918963Characterizing bleeding adverse events associated with BCR-ABL tyrosine kinase inhibitors: insights from FAERS reports
Ranran Liang, Lin Zhang, Yanlin Liu, Houli Zhang et al.
2026-09-09 · DOI: 10.3389/fonc.2026.1912458Efficacy and safety of neoadjuvant immune checkpoint inhibitors combined with chemotherapy in locally advanced hypopharyngeal squamous cell carcinoma: a retrospective analysis
Xueying Liu, Linteng Chen, Aiming Chen, Xian-Yang Luo et al.
2026-09-09 · DOI: 10.3389/fonc.2026.1928173Exceptional 106-month survival in multiply relapsed small cell lung cancer after sequential anlotinib and short-course sintilimab: a case report
Ruzhu Wang, Yishan Lu, Tianshu Yang, Yuting Zhang et al.
2026-09-09 · DOI: 10.3389/fonc.2026.1902026Bispecific antibodies in gastrointestinal cancers: current applications and future perspectives
Mariam Ismail, Noran Al-Gizey, Ebtesam Al-Najjar, Zaid Alabed et al.
2026-09-09 · DOI: 10.3389/fonc.2026.1927829Treating the invisible target: treatment planning targeting the microscopic tumor spread in gliomas
Wille Häger, Iuliana Toma-Dașu, Mehdi Astaraki, Marta Lazzeroni et al.
2026-09-09 · DOI: 10.3389/fonc.2026.1872089Elevated D-dimer levels in high-risk multiple myeloma patients: a systematic review and meta-analysis
Changming Sun, Yiqun Guo, Weichuan Zhao
2026-09-09 · DOI: 10.3389/fonc.2026.1899079Genetic associations link lung cancer liability to brain imaging phenotypes and nominate an FN1-associated tumor–oligodendrocyte program in small-cell lung cancer
Kai Xu, Peihang Xu, Kunsong Su, Zhenkun Liu et al.
2026-09-09 · DOI: 10.3389/fonc.2026.1890325Prognostic and clinicopathological value of perineural invasion in colorectal cancer: a meta-analysis
Xinyue Zhang, Jingtong Tang, Jianping Zhou
2026-09-09 · DOI: 10.3389/fonc.2026.1910736Efficacy and cosmetic outcomes of radiotherapy modalities in early-stage breast cancer: a systematic review and network meta-analysis
Yushan Dong, Tingting Liu, Peng Wang, Songjiang Liu et al.
2026-09-09 · DOI: 10.3389/fonc.2026.1876930Interpretable ensemble learning model using intratumoral and peritumoral multi-sequence MR-radiomics predicts high-grade cervical cancer with lymphovascular space invasion
Fei Wang, Chunyue Yan, Jiqiang He, Xiaolin Tang et al.
2026-09-09 · DOI: 10.3389/fonc.2026.1827751Case Report: Thoracic spinal metastasis without definite intrahepatic recurrence after conversion therapy and hepatectomy for hepatocellular carcinoma
Jiahui Chen, Yanhua Huang, Difan Zhou
2026-09-09 · DOI: 10.3389/fonc.2026.1931013Deep learning prediction of MSI/dMMR, EBV, HER2, PD-L1, and CLDN18.2 status directly from hematoxylin and eosin-stained slides in gastric and gastroesophageal junction adenocarcinoma: a systematic review
Hyuk Lee, Sang Yun Ha, Sehun Kim, Yang Won Min et al.
2026-09-09 · DOI: 10.3389/fonc.2026.1953562Deep and durable response to re-challenge with platinum-based therapy in a platinum-relapsed small cell lung cancer patient following Olvi-Vec oncolytic immunotherapy: a case report
Yun Chen, Zhi-Quan Qin, Zi-Ming Li, Xing-Hao Ai et al.
2026-09-09 · DOI: 10.3389/fonc.2026.1923418A case of invasive lobular carcinoma with signet-ring-cell differentiation treated with multidisciplinary therapy: a rare case report
Haruko Takuwa, Tetsuo Hori, Naoki Goda, Megumi Takeuchi et al.
2026-09-09 · DOI: 10.3389/fonc.2026.1926146Case Report: Concordance of cerebrospinal fluid-derived circulating tumor DNA with tumor tissue in spinal glioblastoma associated with Lynch syndrome
Carlen A. Yuen, David O. Kamson, Changrui Xiao, William H. Yong et al.
2026-09-09 · DOI: 10.3389/fonc.2026.1914228Reviews
Community Reviews
Version History
September 8, 2026 at 12:02 am
September 8, 2026